Omental and Epiploic Conditions
Omental and Epiploic Conditions is a research topic within Rheumatology. Science Explorer counts 4.1k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on omental pathologies such as omental infarction, epiploic appendagitis, and their mimicking conditions. It discusses the diagnostic role of CT imaging, clinical manifestations in pediatric patients, and the management options including surgical and conservative approaches. Additionally, it includes anatomical studies of the omentum.
- Omental Infarction
- Epiploic Appendagitis
- CT Diagnosis
- Abdominal Pain
- Imaging Manifestations
- Pediatric Patients
- Surgical Management
- Radiologic Features
- Conservative Treatment
- Anatomical Study
- Research works
- 4.1k fractional, since 1950
- In the world top 10%
- 415 per year above
- Top-10% rate
- 10.2% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +19% the tick is no change
- Largest producer
United States
29% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Omental and Epiploic Conditions research?
By volume, the United States and China publish the most (156 and 90 works in 2022-now).
By volume, 2022-now
- 1
United States 156 works
- 2
China 90 works
- 3
India 69 works
- 4
Japan 58 works
- 5
Türkiye 33 works
- 6
United Kingdom 33 works
- 7
Russia 30 works
- 8
Brazil 28 works
- 9
Spain 24 works
- 10
Germany 23 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Omental and Epiploic Conditions research?
By volume in 2022-now, All India Institute of Medical Sciences publishes the most Omental and Epiploic Conditions research, followed by Poltava State Medical University and Universidade de São Paulo.
By volume, 2022-now
- 1
All India Institute of Medical Sciences
India 9 works
- 2
Poltava State Medical University
Ukraine 5 works
- 3
Universidade de São Paulo
Brazil 5 works
- 4
Mohammed V University
Morocco 4 works
- 5
Mayo Clinic
United States 4 works
- 6
Weatherford College
United States 4 works
- 7
Tehran University of Medical Sciences
Iran 4 works
- 8
Centre Hospitalier Universitaire Ibn Rochd
Morocco 4 works
- 9
Capital Medical University
China 3 works
- 10
Harvard University
United States 3 works
Where is Omental and Epiploic Conditions research done?
The largest centres of Omental and Epiploic Conditions research in 2022-now are Moscow (Russia), Istanbul (Türkiye), São Paulo (Brazil) and Beijing (China).
Where is the best place to study Omental and Epiploic Conditions?
Among universities, judged by research, All India Institute of Medical Sciences score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | All India Institute of Medical Sciences |
10.0 | 2.2% | 10.5× | 9 | +140.2% |
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Omental and Epiploic Conditions, country by countryIs Omental and Epiploic Conditions research growing?
Output in 2022-2025 was 19% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Omental and Epiploic Conditions.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Omental and Epiploic Conditions as a percentage of every work published that year, 0.0034% in 2024.
Fractional works of Omental and Epiploic Conditions over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Omental and Epiploic Conditions. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.